Humana management check

HUM · Health Care · Managed Health Care · CEO James A. Rechtin

Filings as of

57
Management score, ranked 357th of 487Strongest: clean books. Weakest: owner returns. See the best and worst run in Health Care →

3 good · 2 to watch · 1 flagged, across the seven questions below.

  • Flag

    Have owners done well?

    Trailed its chosen peers

    $100 invested at the start of fiscal 2021 grew to $65, against $108 for the peer group the company picked itself.

  • Watch

    Does pay follow performance?

    Pay only loosely tracked returns

    Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of -0.06 with shareholder return. 1 means pay moved in step; below 0, the opposite way.

  • Watch

    What does the CEO cost owners?

    1.6% of net income

    $18.8m of reported pay in fiscal 2025, against $1.2bn of net income.

  • n/a

    Do they own the stock?

    No recent CEO filing

    No open-market insider buying or selling in the last six months.

  • Good

    Are owners being diluted?

    Share count shrinking

    Diluted shares changed -1.5% a year over the last three fiscal years. Stock-based pay was 0.2% of revenue in the latest year.

  • Good

    Is leadership stable?

    6 leadership filings in 3 years

    CEO in the pay table: Mr. Rechtin. 6 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.

  • Good

    Are the books clean?

    No red flags on file

    No restatements, auditor changes or late filings since 2021.

Against the S&P 500

Each check's score (0–100) and how it compares: the share of ranked S&P 500 companies it matches or beats, and the median in Health Care.

CheckScoreAt or aboveSector median
Owner returns016%26
Pay for performance4710%85
CEO cost3436%44
Skin in the game——46
Dilution6859%68
Stable leadership9575%70
Clean books100100%100

Closest peers

Others in Managed Health Care, by management score. Humana is 43rd of 60 in its sector.

  1. 76ELVElevance Health78
  2. 353BDXBecton Dickinson58
  3. 357HUMHumana57
  4. 362CVSCVS Health57
  5. 446CNCCentene Corporation47
  6. 460UNHUnitedHealth Group42

Pay versus performance

From the proxy statement filed March 6, 2026. "Actually paid" values stock awards at the share price, so it rises and falls with the stock.

CEO pay by fiscal yearAs reported Actually paid
−$37.7m−$3.7m$30.4m20212022202320242025
What $100 becameCompany Peer group
$10020212022202320242025$65
Fiscal yearCEOCEO payActually paidOther executives (avg)$100 becamePeersNet income
2025Mr. Rechtin$18.8m$18.8m$9.4m$65$108$1.2bn
2024—$15.6m$9.2m$10.1m$64$107$1.2bn
2023—$16.3m−$37.7m$3.9m$114$115$2.5bn
2022—$17.2m$30.4m$4.2m$126$116$2.8bn
2021—$16.5m$25.8m$4.1m$114$125$2.9bn

The board says pay is tied most to Adjusted EPS. Its other key measures: Pre-Tax Earnings, Relative Total Shareholder Return.

Insiders and the CEO's stake

James A. Rechtin (President & CEO) held 63,938 shares directly after their latest Form 4 on May 1, 2026.

No open-market insider buying or selling in the last six months.

Leadership and governance on file

Latest shareholder vote results: Apr 20, 2026, including the say-on-pay vote.

Where the money went

Over 2021–2025: $6.8bn returned to owners in buybacks and dividends, 64% of net income, and $1.0bn of pay in stock.

Fiscal year20212022202320242025
Revenue$83.1bn$92.9bn$106.4bn$117.8bn$129.7bn
Net income$2.9bn$2.8bn$2.5bn$1.2bn$1.2bn
Stock-based pay$180.0m$216.0m$175.0m$207.0m$241.0m
Buybacks$79.0m$2.1bn$1.6bn$817.0m$151.0m
Dividends$354.0m$392.0m$431.0m$431.0m$430.0m
Diluted shares129m127m124m121m121m

Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.